High-Purity CMEE and CEE for Drug Synthesis and API Production
Specialty chemicals like CMEE and CEE serve as critical building blocks in pharmaceutical synthesis, enabling production of essential medicines and vitamin supplements.
The global pharmaceutical intermediates market exceeded $85 billion in 2024, with specialty alkylating agents and esterification reagents playing essential roles in API manufacturing. China supplies over 40% of global pharmaceutical intermediates.
CMEE provides selective alkylation capabilities for pharmaceutical synthesis with excellent yield and purity. CEE enables efficient cyanoethylation reactions critical for Vitamin B1 production and specialty drug intermediates. Both offer superior reactivity compared to alternative reagents.
Pharmaceutical-grade chemicals must meet stringent purity specifications, with comprehensive certificates of analysis, stability data, and regulatory documentation. Our products support GMP manufacturing environments with full traceability and quality assurance.
CMEE and CEE enable synthesis of essential pharmaceutical products and active pharmaceutical ingredients.
Cyanoethyl ester (CEE) is a critical intermediate in commercial Vitamin B1 manufacturing, used globally in dietary supplements and pharmaceutical formulations.
Recommended Product: Cyanoethyl Ester (CEE) pharmaceutical grade with >99% purity
Chloromethyl ethyl ether (CMEE) serves as a key intermediate in manufacturing general and local anesthetic compounds used in surgical and medical procedures.
Recommended Product: Chloromethyl Ethyl Ether (CMEE) technical grade for pharmaceutical synthesis
Both CMEE and CEE function as versatile building blocks in multi-step synthesis of complex pharmaceutical active ingredients.
Recommended Products: Both CMEE and CEE depending on specific synthetic route requirements
CMEE and CEE enable synthesis of specialized pharmaceutical compounds including orphan drugs, biologics intermediates, and novel therapeutic agents.
Application Note: Custom synthesis and scale-up support available for novel pharmaceutical applications
Why pharmaceutical manufacturers choose CMEE and CEE for critical synthesis steps.
Pharmaceutical-grade purity (>99%) with low impurity profiles ensures consistent reaction outcomes and simplified downstream purification. Complete certificates of analysis (CoA) with GC-MS data, water content, and trace metal analysis provided with every batch.
CMEE provides highly selective chloromethylation without competing side reactions. CEE offers clean Michael addition chemistry with predictable regioselectivity. Both reagents operate under mild conditions (0-80°C) compatible with sensitive pharmaceutical intermediates.
Optimized synthesis routes using CMEE and CEE achieve 80-95% isolated yields in pharmaceutical applications. High reactivity reduces reaction times and minimizes formation of unwanted byproducts. Efficient atom economy reduces waste generation and raw material costs.
Proven performance from lab-scale (gram) to production-scale (multi-ton) manufacturing. Consistent batch-to-batch quality enables reliable process scale-up. Compatible with standard pharmaceutical manufacturing equipment including glass-lined reactors and stainless steel vessels.
Comprehensive technical documentation including specifications, test methods, stability data, and safety information. Support for Drug Master Files (DMF) and regulatory submissions. Material Safety Data Sheets (MSDS) and handling guidelines provided. Audit support for GMP compliance verification.
Consistent supply from dedicated manufacturing facilities in China. Quality management system aligned with pharmaceutical industry standards. Secure supply chain with inventory management and logistics support. Technical service team available for application support and troubleshooting.
High-purity specialty chemicals for pharmaceutical synthesis and API manufacturing.
Every batch of pharmaceutical-grade CMEE and CEE undergoes comprehensive testing:
Storage & Handling: Supplied in sealed containers with inert atmosphere. Store in cool, dry, well-ventilated areas away from incompatible materials. Shelf life: 12-24 months under proper storage conditions.
Regulatory Support: Technical dossiers available for Drug Master File (DMF) support. Assistance with regulatory submissions and GMP audits.
Technical considerations for using CMEE and CEE in pharmaceutical manufacturing.
| Parameter | CMEE | CEE |
|---|---|---|
| Typical Reaction Temperature | 0-50°C | 20-80°C |
| Common Solvents | THF, DCM, toluene, DMF | Ethanol, THF, DMF, acetonitrile |
| Typical Catalysts/Bases | NaH, K₂CO₃, DBU | NaOEt, KOH, NaH |
| Reaction Time | 2-12 hours | 4-24 hours |
| Molar Equivalents | 1.1-2.0 eq. excess | 1.0-1.5 eq. excess |
| Typical Yields | 75-95% | 80-95% |
| Atmosphere Requirements | Inert (N₂ or Ar) | Inert (N₂ or Ar) |
| Moisture Sensitivity | Moderate | Low to moderate |
| Workup Method | Aqueous extraction, distillation | Aqueous extraction, crystallization |
| Purification | Distillation, column chromatography | Recrystallization, chromatography |
| Storage Temperature | 2-8°C recommended | Room temperature acceptable |
| Shelf Life | 12 months (sealed, cold) | 24 months (sealed) |
CMEE: Flammable liquid. Use in well-ventilated areas with appropriate engineering controls. Avoid contact with strong oxidizers. Handle under inert atmosphere when possible.
CEE: Moderate toxicity. Use standard laboratory safety protocols including fume hood, gloves, and eye protection. Avoid skin contact and inhalation.
Both: Dispose of waste according to local regulations. Maintain MSDS readily available. Train personnel on proper handling procedures.
Temperature Control: Maintain precise temperature control to maximize selectivity. Exothermic reactions may require cooling.
Stoichiometry: Slight excess of CMEE/CEE often improves conversion. Optimize based on specific substrate reactivity.
Order of Addition: Add reagents slowly to control reaction rate and prevent side reactions. Consider inverse addition for sensitive substrates.
In-Process Monitoring: Use TLC or HPLC to monitor reaction progress. GC-MS can identify impurities and byproducts.
Product Analysis: Confirm structure by NMR spectroscopy. Verify purity by HPLC (pharmaceutical applications require >98% purity).
Batch Documentation: Maintain complete records of reagent lots, reaction conditions, and analytical results for regulatory compliance.
Real-world pharmaceutical synthesis using CMEE and CEE.
Challenge: Vitamin manufacturer needed reliable supply of high-purity CEE for continuous production of pharmaceutical-grade thiamine hydrochloride at 200+ ton annual capacity.
Solution: Implemented Cyanoethyl Ester (CEE) from Hebei Sukeleshi with pharmaceutical-grade specifications and consistent batch-to-batch quality.
Results:
Product Used: Cyanoethyl Ester (CEE) pharmaceutical grade, 99.5% minimum purity
Challenge: Pharmaceutical company developing generic local anesthetic required CMEE for key alkylation step in multi-step synthesis. Previous supplier had quality variability causing batch failures.
Solution: Qualified Chloromethyl Ethyl Ether (CMEE) from Hebei Sukeleshi through comprehensive testing including impurity profiling and stability studies.
Results:
Product Used: Chloromethyl Ethyl Ether (CMEE) pharmaceutical grade with complete CoA
Challenge: CRO synthesizing novel cardiovascular drug candidate needed flexible supply of both CMEE and CEE for medicinal chemistry optimization across 50+ structural analogs.
Solution: Established supply agreement with Hebei Sukeleshi for both products with flexible ordering (1-50 kg lots) and technical support for synthesis troubleshooting.
Results:
Products Used: Both CMEE and CEE pharmaceutical grade for medicinal chemistry applications
Our pharmaceutical-grade specialty chemicals meet stringent purity requirements for drug synthesis and API manufacturing. Request certificates of analysis, technical specifications, or production samples for evaluation in your pharmaceutical processes.
